Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000315 | organellar large ribosomal subunit | 5 | 1 |
GO:0005762 | mitochondrial large ribosomal subunit | 3 | 1 |
GO:0015934 | large ribosomal subunit | 4 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0044391 | ribosomal subunit | 3 | 1 |
GO:0098798 | mitochondrial protein-containing complex | 2 | 1 |
GO:1990904 | ribonucleoprotein complex | 2 | 1 |
Related structures:
AlphaFold database: E9B0N5
Term | Name | Level | Count |
---|---|---|---|
GO:0006415 | translational termination | 6 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016043 | cellular component organization | 3 | 1 |
GO:0022411 | cellular component disassembly | 4 | 1 |
GO:0032984 | protein-containing complex disassembly | 5 | 1 |
GO:0043933 | protein-containing complex organization | 4 | 1 |
GO:0070126 | mitochondrial translational termination | 7 | 1 |
GO:0071840 | cellular component organization or biogenesis | 2 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 11 |
GO:0003747 | translation release factor activity | 5 | 11 |
GO:0005488 | binding | 1 | 11 |
GO:0008079 | translation termination factor activity | 4 | 11 |
GO:0008135 | translation factor activity, RNA binding | 3 | 11 |
GO:0045182 | translation regulator activity | 1 | 11 |
GO:0090079 | translation regulator activity, nucleic acid binding | 2 | 11 |
GO:0097159 | organic cyclic compound binding | 2 | 11 |
GO:1901363 | heterocyclic compound binding | 2 | 11 |
GO:0003824 | catalytic activity | 1 | 1 |
GO:0004045 | aminoacyl-tRNA hydrolase activity | 5 | 1 |
GO:0016150 | translation release factor activity, codon nonspecific | 6 | 1 |
GO:0016787 | hydrolase activity | 2 | 1 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 1 |
GO:0052689 | carboxylic ester hydrolase activity | 4 | 1 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 1 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 1 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 126 | 128 | PF00675 | 0.259 |
CLV_NRD_NRD_1 | 161 | 163 | PF00675 | 0.559 |
CLV_NRD_NRD_1 | 93 | 95 | PF00675 | 0.352 |
CLV_PCSK_KEX2_1 | 160 | 162 | PF00082 | 0.563 |
CLV_PCSK_KEX2_1 | 93 | 95 | PF00082 | 0.331 |
CLV_PCSK_SKI1_1 | 116 | 120 | PF00082 | 0.367 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.413 |
DOC_ANK_TNKS_1 | 54 | 61 | PF00023 | 0.436 |
DOC_USP7_MATH_1 | 100 | 104 | PF00917 | 0.474 |
DOC_USP7_MATH_1 | 21 | 25 | PF00917 | 0.545 |
LIG_14-3-3_CanoR_1 | 127 | 133 | PF00244 | 0.542 |
LIG_14-3-3_CanoR_1 | 135 | 139 | PF00244 | 0.591 |
LIG_14-3-3_CanoR_1 | 169 | 179 | PF00244 | 0.592 |
LIG_BRCT_BRCA1_1 | 80 | 84 | PF00533 | 0.449 |
LIG_FHA_1 | 104 | 110 | PF00498 | 0.492 |
LIG_FHA_1 | 9 | 15 | PF00498 | 0.627 |
LIG_LIR_Apic_2 | 137 | 141 | PF02991 | 0.530 |
LIG_LIR_Nem_3 | 30 | 36 | PF02991 | 0.568 |
LIG_MLH1_MIPbox_1 | 80 | 84 | PF16413 | 0.492 |
LIG_NRBOX | 128 | 134 | PF00104 | 0.531 |
LIG_PCNA_PIPBox_1 | 77 | 86 | PF02747 | 0.492 |
LIG_SH2_STAT3 | 34 | 37 | PF00017 | 0.577 |
LIG_SH3_3 | 144 | 150 | PF00018 | 0.591 |
LIG_SUMO_SIM_par_1 | 106 | 111 | PF11976 | 0.451 |
MOD_CK1_1 | 103 | 109 | PF00069 | 0.508 |
MOD_CK1_1 | 173 | 179 | PF00069 | 0.686 |
MOD_CK1_1 | 24 | 30 | PF00069 | 0.492 |
MOD_CK2_1 | 108 | 114 | PF00069 | 0.454 |
MOD_CK2_1 | 13 | 19 | PF00069 | 0.719 |
MOD_CK2_1 | 24 | 30 | PF00069 | 0.612 |
MOD_GlcNHglycan | 116 | 119 | PF01048 | 0.259 |
MOD_GlcNHglycan | 172 | 175 | PF01048 | 0.631 |
MOD_GlcNHglycan | 56 | 59 | PF01048 | 0.310 |
MOD_GSK3_1 | 148 | 155 | PF00069 | 0.536 |
MOD_GSK3_1 | 164 | 171 | PF00069 | 0.572 |
MOD_GSK3_1 | 21 | 28 | PF00069 | 0.471 |
MOD_GSK3_1 | 50 | 57 | PF00069 | 0.482 |
MOD_GSK3_1 | 61 | 68 | PF00069 | 0.462 |
MOD_GSK3_1 | 9 | 16 | PF00069 | 0.585 |
MOD_GSK3_1 | 99 | 106 | PF00069 | 0.524 |
MOD_N-GLC_1 | 64 | 69 | PF02516 | 0.221 |
MOD_NEK2_1 | 170 | 175 | PF00069 | 0.532 |
MOD_NEK2_1 | 54 | 59 | PF00069 | 0.533 |
MOD_NEK2_1 | 9 | 14 | PF00069 | 0.670 |
MOD_PKA_1 | 162 | 168 | PF00069 | 0.608 |
MOD_PKA_2 | 134 | 140 | PF00069 | 0.639 |
MOD_PKA_2 | 148 | 154 | PF00069 | 0.626 |
MOD_PKA_2 | 168 | 174 | PF00069 | 0.410 |
MOD_PKA_2 | 21 | 27 | PF00069 | 0.570 |
MOD_PKA_2 | 54 | 60 | PF00069 | 0.494 |
MOD_PKB_1 | 160 | 168 | PF00069 | 0.615 |
MOD_Plk_4 | 104 | 110 | PF00069 | 0.531 |
MOD_Plk_4 | 128 | 134 | PF00069 | 0.453 |
MOD_Plk_4 | 148 | 154 | PF00069 | 0.436 |
MOD_Plk_4 | 9 | 15 | PF00069 | 0.480 |
MOD_SUMO_rev_2 | 151 | 159 | PF00179 | 0.697 |
TRG_DiLeu_BaEn_2 | 147 | 153 | PF01217 | 0.582 |
TRG_ENDOCYTIC_2 | 33 | 36 | PF00928 | 0.570 |
TRG_ER_diArg_1 | 159 | 162 | PF00400 | 0.600 |
TRG_ER_diArg_1 | 92 | 94 | PF00400 | 0.529 |
TRG_NLS_MonoExtN_4 | 160 | 166 | PF00514 | 0.559 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I3M0 | Leptomonas seymouri | 77% | 100% |
A0A0S4IXK6 | Bodo saltans | 49% | 85% |
A0A3S7X372 | Leishmania donovani | 94% | 89% |
A0A422P522 | Trypanosoma rangeli | 53% | 69% |
A4HI61 | Leishmania braziliensis | 82% | 100% |
A4I5D7 | Leishmania infantum | 94% | 89% |
C9ZQR8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 53% | 79% |
Q4Q7J7 | Leishmania major | 95% | 100% |
V5BZ05 | Trypanosoma cruzi | 55% | 68% |